Enanta Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
68.22
|
|
Average Rating
|
3.90
|
|
# Strong Buys
|
3
|
|
# Buys
|
3
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.35
|
-1.27
|
0.08
|
5.93%
|
|
2022-06-30
|
-1.39
|
-1.53
|
-0.14
|
-10.07%
|
|
2022-03-31
|
-1.43
|
-1.63
|
-0.20
|
-13.99%
|
|
2021-12-31
|
-1.08
|
-1.48
|
-0.40
|
-37.04%
|
|
2021-09-30
|
-1.22
|
-1.22
|
0.00
|
0.00%
|
|
2021-06-30
|
-1.28
|
-1.19
|
0.09
|
7.03%
|
|
2021-03-31
|
-0.98
|
-1.09
|
-0.11
|
-11.22%
|
|
2020-12-31
|
-0.74
|
-0.41
|
0.33
|
44.59%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.00
|
|
2022-09-30
|
-5.91
|
|
2021-09-30
|
-3.91
|
|
2020-09-30
|
-1.82
|
|
2019-09-30
|
2.22
|
|
2018-09-30
|
3.47
|
|
2017-09-30
|
0.88
|
|
2016-09-30
|
1.12
|
|
2015-09-30
|
4.09
|
|
2014-09-30
|
0.97
|
|
2013-09-30
|
-2.76
|